Healthcare -
Biotechnology - NASDAQ - US
$ 9.97
-0.103 %
$ 460 M
Market Cap
-3.26
P/E
URGN - CAPITAL EXPENDITURES
Capital Expenditures URGN - UroGen Pharma Ltd.
-295 K
LAST VALUE
-7.77%
2 YEAR CAGR
1.92%
5 YEAR CAGR
-28.52%
10 YEAR CAGR